International Clinical Trial: A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731685) titled 'A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases' on July 23.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Condition: Pain in Bone Metastases

Intervention: Drug: VC004 low dose Drug: VC004 high dose

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: July 30, 2026

Target Sample Size: 26

Co...